(1.85%) 5 222.68 points
(2.16%) 39 513 points
(-0.03%) 16 341 points
(-0.29%) $78.03
(-1.02%) $2.23
(-0.31%) $2 367.60
(-0.44%) $28.38
(-0.35%) $1 003.70
(0.11%) $0.928
(-0.10%) $10.85
(-0.01%) $0.798
(-0.32%) $92.25
@ $3.65
Issued: 14 Feb 2024 @ 13:53
Return: 53.97%
Previous signal: Feb 13 - 11:05
Previous signal:
Return: -1.62 %
Live Chart Being Loaded With Signals
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform...
Stats | |
---|---|
Today's Volume | 525 905 |
Average Volume | 913 459 |
Market Cap | 687.43M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.230 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -10.41 |
ATR14 | $0.0100 (0.18%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-03 | Moran Kyle | Sell | 15 630 | Ordinary Shares |
2024-02-05 | Francis Chris | Buy | 286 400 | Share Option (right to buy) |
2024-02-05 | Bolno Paul | Buy | 1 008 600 | Share Option (right to buy) |
2024-02-05 | Moran Kyle | Buy | 371 500 | Share Option (right to buy) |
2024-02-05 | Vargeese Chandra | Buy | 361 700 | Share Option (right to buy) |
INSIDER POWER |
---|
98.54 |
Last 99 transactions |
Buy: 37 730 786 | Sell: 301 457 |
Volume Correlation
WAVE Life Sciences Ltd Correlation
10 Most Positive Correlations | |
---|---|
MNKD | 0.83 |
SISI | 0.829 |
ORGS | 0.827 |
ICLR | 0.825 |
GOODM | 0.824 |
VTYX | 0.822 |
APLT | 0.816 |
PAIC | 0.815 |
DRRX | 0.814 |
MTSL | 0.814 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
WAVE Life Sciences Ltd Correlation - Currency/Commodity
WAVE Life Sciences Ltd Financials
Annual | 2023 |
Revenue: | $113.31M |
Gross Profit: | $104.10M (91.88 %) |
EPS: | $-0.540 |
FY | 2023 |
Revenue: | $113.31M |
Gross Profit: | $104.10M (91.88 %) |
EPS: | $-0.540 |
FY | 2022 |
Revenue: | $3.65M |
Gross Profit: | $-6.47M (-177.17 %) |
EPS: | $-2.05 |
FY | 2021 |
Revenue: | $40.96M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.36 |
Financial Reports:
No articles found.
WAVE Life Sciences Ltd
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders. In addition, it focuses on developing GalNAc-conjugated AIMers to treat hepatic indications comprising Alpha-1 antitrypsin deficiency (AATD); and two preclinical programs, such as Usher syndrome type 2A (USH2A) and retinitis pigmentosa due to a P23H mutation in the RHO gene (RhoP23H) for the treatment of retinal diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, University of Massachusetts, Western Washington University, Grenoble Institute of Neurosciences, IRBM S.p.A, University of Louisville, and University College London. The company was incorporated in 2012 and is based in Singapore.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators